Cialis (Tadalfil) is in a class of drugs called phophodiesterase inhibitors. FDA approved Tadalfil - Cialis in 2003 for the treatment of men who experience difficulty having and maintaining an erection.

Cialis (Tadalfil), an oral treatment for Erectile Dysfunction (ED) in men, is a selective inhibitor of cyclic quanosine monophosphate (cGMP) - specific phophodiesterase type 5 (PDE 5).

Cialis is available in the form of tablets which contains 5, 10 or 20 mg of Tadalfil and inactive ingredients like croscarmellose sodium, hydroxpropyl cellulose, hypromellose, iron oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulphate, talc, titanium dioxide and triacetin.

Recommended dose of Cialis in most patients is 10mg taken prior to sexual intercourse. Both Cialis and Viagra work in the same way, by helping blood vessels in the penis to relax allowing blood to flow into the penis causing an erection.

Cialis is slightly different from the other ED drugs available in the market as it may work up to 36 hrs after dosing.

Cialis is available online with various sites offering cheap Cialis. Forzest is the Indian answer to Cialis and is manufactured by Ranbaxy Laboratories Ltd. Forzest is same as Tadalfil and is also known as Generic Cialis.

When Generic Cialis Online prescribes and while buying it on the net there may be a choice between a brand - name medicine and the generic version of that medicine.

Generic Cialis is available online and one can buy generic Cialis from these legal sites. There are variants of Generic Cialis available in the market - they are called generic Cialis or generic Tadalfil. They have the same composition as the branded Cialis. One can buy generic drugs as they only may look different because in the US, FDA does not allow it to look the same. Colors, flavors and certain other inactive ingredients may be different but the core ingredient remains the same.

As most of the drugs fall under the patent law many companies are lining up to manufacture generic forms of the brand name drugs going off patent. Many Indian companies are in the race for regulatory approval to introduce medicines in the highly lucrative North American market.